These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22735949)

  • 21. A small bispecific protein selected for orthogonal affinity purification.
    Alm T; Yderland L; Nilvebrant J; Halldin A; Hober S
    Biotechnol J; 2010 Jun; 5(6):605-17. PubMed ID: 20518064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo.
    Lindborg M; Cortez E; Höidén-Guthenberg I; Gunneriusson E; von Hage E; Syud F; Morrison M; Abrahmsén L; Herne N; Pietras K; Frejd FY
    J Mol Biol; 2011 Mar; 407(2):298-315. PubMed ID: 21277312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold.
    Juraja SM; Mulhern TD; Hudson PJ; Hattarki MK; Carmichael JA; Nuttall SD
    Protein Eng Des Sel; 2006 May; 19(5):231-44. PubMed ID: 16549402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
    Löfdahl PA; Nord O; Janzon L; Nygren PA
    N Biotechnol; 2009 Nov; 26(5):251-9. PubMed ID: 19576305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid isolation of high-affinity protein binding peptides using bacterial display.
    Bessette PH; Rice JJ; Daugherty PS
    Protein Eng Des Sel; 2004 Oct; 17(10):731-9. PubMed ID: 15531628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy.
    Nilsson FY; Tolmachev V
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):167-75. PubMed ID: 17436552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affinity-based entrapment of the HER2 receptor in the endoplasmic reticulum using an affibody molecule.
    Vernet E; Konrad A; Lundberg E; Nygren PA; Gräslund T
    J Immunol Methods; 2008 Sep; 338(1-2):1-6. PubMed ID: 18671978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering novel binding proteins from nonimmunoglobulin domains.
    Binz HK; Amstutz P; Plückthun A
    Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing scaffolds of peptides for phage display libraries.
    Uchiyama F; Tanaka Y; Minari Y; Tokui N
    J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered two-helix small proteins for molecular recognition.
    Webster JM; Zhang R; Gambhir SS; Cheng Z; Syud FA
    Chembiochem; 2009 May; 10(8):1293-6. PubMed ID: 19422008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders.
    Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS
    Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro selection from protein and peptide libraries.
    Clackson T; Wells JA
    Trends Biotechnol; 1994 May; 12(5):173-84. PubMed ID: 7764900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
    Ebersbach H; Fiedler E; Scheuermann T; Fiedler M; Stubbs MT; Reimann C; Proetzel G; Rudolph R; Fiedler U
    J Mol Biol; 2007 Sep; 372(1):172-85. PubMed ID: 17628592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Affibody ligands binding interleukin-2 receptor alpha/CD25.
    Grönwall C; Snelders E; Palm AJ; Eriksson F; Herne N; Ståhl S
    Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):97-112. PubMed ID: 18284375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering an ultra-stable affinity reagent based on Top7.
    Boschek CB; Apiyo DO; Soares TA; Engelmann HE; Pefaur NB; Straatsma TP; Baird CL
    Protein Eng Des Sel; 2009 May; 22(5):325-32. PubMed ID: 19321520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A ticket to ride: peptide radiopharmaceuticals.
    Fischman AJ; Babich JW; Strauss HW
    J Nucl Med; 1993 Dec; 34(12):2253-63. PubMed ID: 8254420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity chromatography matures as bioinformatic and combinatorial tools develop.
    Clonis YD
    J Chromatogr A; 2006 Jan; 1101(1-2):1-24. PubMed ID: 16242704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.